Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth

被引:168
作者
Nishihira, J [1 ]
机构
[1] Hokkaido Univ, Sch Med, Cent Res Inst, Kita Ku, Sapporo, Hokkaido 060, Japan
关键词
D O I
10.1089/10799900050151012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophage migration inhibitory factor (MIF) functions as a pleiotropic protein, participating in inflammatory and immune responses. MIF was originally discovered as a lymphokine involved in delayed hypersensitivity and various macrophage functions, including phagocytosis, spreading, and tumoricidal activity, Recently, MIF was reevaluated as a proinflammatory cytokine and pituitary-derived hormone potentiating endotoxemia. This protein is ubiquitously expressed in various organs, such as the brain and kidney. Among cytokines, MIF is unique in terms of its abundant expression and storage within the cytoplasm and, further, for its counteraction against glucocorticoids. MIF has unexpectedly been found to convert D-dopachrome, an enantiomer of naturally occurring L-dopachrome, to 5,6-dihydroxyindole, However, its physiologic significance remains to be elucidated. It was demonstrated that anti-MIF antibodies effectively suppress tumor growth and tumor-associated angiogenesis, suggesting that MIF is involved not only in inflammatory and immune responses but also in tumor cell growth. At present, MIF cannot be clearly categorized as either a cytokine, hormone, or enzyme. This review presents the latest findings on the role of MIF in the immune system and in cell growth, with regard to tumorigenesis and wound repair, and discusses its potential functions in various pathophysiologic states.
引用
收藏
页码:751 / 762
页数:12
相关论文
共 77 条
  • [1] Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts
    Abe, R
    Shimizu, T
    Ohkawara, AA
    Nishihira, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1500 (01): : 1 - 9
  • [2] Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts
    Arcuri, F
    Cintorino, M
    Vatti, R
    Carducci, A
    Liberatori, S
    Paulesu, L
    [J]. BIOLOGY OF REPRODUCTION, 1999, 60 (06) : 1299 - 1303
  • [3] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
    Bacher, M
    Metz, CN
    Calandra, T
    Mayer, K
    Chesney, J
    Lohoff, M
    Gemsa, D
    Donnelly, T
    Bucala, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7849 - 7854
  • [4] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA
    BERNHAGEN, J
    CALANDRA, T
    MITCHELL, RA
    MARTIN, SB
    TRACEY, KJ
    VOELTER, W
    MANOGUE, KR
    CERAMI, A
    BUCALA, R
    [J]. NATURE, 1993, 365 (6448) : 756 - 759
  • [5] PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF)
    BERNHAGEN, J
    MITCHELL, RA
    CALANDRA, T
    VOELTER, W
    CERAMI, A
    BUCALA, R
    [J]. BIOCHEMISTRY, 1994, 33 (47) : 14144 - 14155
  • [6] An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
    Bernhagen, J
    Bacher, M
    Calandra, T
    Metz, CN
    Doty, SB
    Donnelly, T
    Bucala, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 277 - 282
  • [7] Protein expression profiles in human breast ductal carcinoma and histologically normal tissue
    Bini, L
    Magi, B
    Marzocchi, B
    Arcuri, F
    Tripodi, S
    Cintorino, M
    Sanchez, JC
    Frutiger, S
    Hughes, G
    Pallini, V
    Hochstrasser, DF
    Tosi, P
    [J]. ELECTROPHORESIS, 1997, 18 (15) : 2832 - 2841
  • [8] MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY
    BLOOM, BR
    BENNETT, B
    [J]. SCIENCE, 1966, 153 (3731) : 80 - &
  • [9] Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
    Bozza, M
    Satoskar, AR
    Lin, GS
    Lu, B
    Humbles, AA
    Gerard, C
    David, JR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) : 341 - 346
  • [10] Brown FG, 1999, CLIN EXP IMMUNOL, V118, P329